MedPath

Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences

Not Applicable
Recruiting
Conditions
Multiple Sclerosis (MS)
Interventions
Procedure: SC MRI
Other: patient questionnaire
Registration Number
NCT04819737
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.

Detailed Description

An averaged magnetization inversion recovery acquisitions (AMIRA) sequence was proposed for SC MRI. This MR-sequence delivers excellent contrast between the SC gray and white matter as well as between the SC and cerebrospinal fluid (CSF) in clinically feasible-acquisition times. Moreover, the high quality and in-plane resolution of AMIRA images allows for segmentation of the SC gray and white matter with high accuracy and reproducibility. This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Diagnosis of multiple sclerosis according to established international criteria
  • Steroid free period: > 4 weeks
  • Participation in the Swiss MS Cohort (SMSC) study
Exclusion Criteria
  • . History of severe (other) neurological, internal or psychiatric disease with SC affection

  • MRI-related exclusion criteria (questionnaire):

    1. Paramagnetic and/or superparamagnetic foreign objects in the body (especially when located close to the SC)
    2. Pacemaker
    3. Claustrophobia
    4. Pregnancy, lactation
    5. Known hypersensitivity to gadolinium-based contrast media

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Spinal Cord MRISC MRI-
Spinal Cord MRIpatient questionnaire-
Primary Outcome Measures
NameTimeMethod
Presence of ongoing inflammation (acute or chronic) in the SCone time assessment (60 minutes scheduled per patient for the MRI part including preparation time outside of the scanner and actual scanning time)

Presence of ongoing inflammation (acute or chronic) in the SC 3D MPRAGE and 3D fluid-attenuated inversion recovery images after intravenous gadolinium (Gd) contrast administration (0.1 mmol per kg body weight)

Number of SC lesionsone time assessment (60 minutes scheduled per patient for the MRI part including preparation time outside of the scanner and actual scanning time)

Number of SC lesions using AMIRA compared to gold-standard conventional SC MRI sequences

Inter-observer agreement on SC lesion countone time assessment (60 minutes scheduled per patient for the MRI part including preparation time outside of the scanner and actual scanning time)

Inter-observer agreement with regard to lesion detection using AMIRA compared to gold-standard conventional SC MRI sequences.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Basel, Department of Neurology

🇨🇭

Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath